Skip to main content

Table 3 Parasite clearance on Days 2 and 3 of treatment

From: In vivo efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo

 

ASAQ

AL

p value

Patients with parasite positivity at D2

18 (13.7 %)

27 (20.0 %)

0.173

Patients with parasite positivity at D3

2 (1.5 %)

6 (4.4 %)

0.167